|
1
|
Liuzzo JP, Ambrose JA and Coppola JT:
Sirolimus- and taxol-eluting stents differ towards intimal
hyperplasia and re-endothelialization. J Invasive Cardiol.
17:497–502. 2005.PubMed/NCBI
|
|
2
|
Weis M and von Scheidt W: Cardiac
allograft vasculopathy: A review. Circulation. 96:2069–2077. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Newby AC and George SJ: Proliferation,
migration, matrix turnover, and death of smooth muscle cells in
native coronary and vein graft atherosclerosis. Curr Opin Cardiol.
11:574–582. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Task Force on Myocardial Revascularization
of the European Society of Cardiology (ESC) and the European
Association for Cardio-Thoracic Surgery (EACTS)1; European
Association for Percutaneous Cardiovascular Interventions (EAPCI).
Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg
S, Huber K, et al: Guidelines on myocardial revascularization. Eur
Heart J. 31:2501–2555. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schamroth CL and Sacks AD: Aortocoronary
saphenous vein bypass aneurysm-an unusual presentation. S Afr Med
J. 88:(Suppl 2). C91–C93. 1998.PubMed/NCBI
|
|
6
|
Gibbons GH and Dzau VJ: The emerging
concept of vascular remodeling. N Engl J Med. 330:1431–1438. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mehta RH, Ferguson TB, Lopes RD, Hafley
GE, Mack MJ, Kouchoukos NT, Gibson CM, Harrington RA, Califf RM,
Peterson ED, et al: Saphenous vein grafts with multiple versus
single distal targets in patients undergoing coronary artery bypass
surgery: One-year graft failure and five-year outcomes from the
Project of Ex-Vivo Vein Graft Engineering via Transfection
(PREVENT) IV trial. Circulation. 124:280–288. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Haruguchi H and Teraoka S: Intimal
hyperplasia and hemodynamic factors in arterial bypass and
arteriovenous grafts: A review. J Artif Organs. 6:227–235. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang LN, Parkinson JF, Haskell C and Wang
YX: Mechanisms of intimal hyperplasia learned from a murine carotid
artery ligation model. Curr Vasc Pharmacol. 6:37–43. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kumar A, Hoover JL, Simmons CA, Lindner V
and Shebuski RJ: Remodeling and neointimal formation in the carotid
artery of normal and P-selectin-deficient mice. Circulation.
96:4333–4342. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kumar A and Lindner V: Remodeling with
neointima formation in the mouse carotid artery after cessation of
blood flow. Arterioscler Thromb Vasc Biol. 17:2238–2244. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kang N, Ng CS, Hu J, Qiu ZB, Underwood MJ,
Jeremy JY and Wan S: Role of osteopontin in the development of
neointimal hyperplasia in vein grafts. Eur J Cardiothorac Surg.
41:1384–1389. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li G, Oparil S, Sanders JM, Zhang L, Dai
M, Chen LB, Conway SJ, McNamara CA and Sarembock IJ:
Phosphatidylinositol-3-kinase signaling mediates vascular smooth
muscle cell expression of periostin in vivo and in vitro.
Atherosclerosis. 188:292–300. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Han XJ, Chen M, Hong T, Zhu LY, He D, Feng
JG and Jiang LP: Lentivirus-mediated RNAi knockdown of the gap
junction protein, Cx43, attenuates the development of vascular
restenosis following balloon injury. Int J Mol Med. 35:885–892.
2015.PubMed/NCBI
|
|
15
|
McDonald RA, White KM, Wu J, Cooley BC,
Robertson KE, Halliday CA, McClure JD, Francis S, Lu R, Kennedy S,
et al: miRNA-21 is dysregulated in response to vein grafting in
multiple models and genetic ablation in mice attenuates neointima
formation. Eur Heart J. 34:1636–1643. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Makarova OV, Makarov EM and Lührmann R:
The 65 and 110 kDa SR-related proteins of the U4/U6.U5 tri-snRNP
are essential for the assembly of mature spliceosomes. EMBO J.
20:2553–2563. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang H, Ji X, Liu X, Yao R, Chi J, Liu S,
Wang Y, Cao W and Zhou Q: Lentivirus-mediated inhibition of USP39
suppresses the growth of breast cancer cells in vitro. Oncol Rep.
30:2871–2877. 2013.PubMed/NCBI
|
|
18
|
Rios Y, Melmed S, Lin S and Liu NA:
Zebrafish usp39 mutation leads to rb1 mRNA splicing defect and
pituitary lineage expansion. PLoS Genet. 7:e10012712011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wen D, Xu Z, Xia L, Liu X, Tu Y, Lei H,
Wang W, Wang T, Song L, Ma C, et al: Important role of SUMOylation
of Spliceosome factors in prostate cancer cells. J Proteome Res.
13:3571–3582. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
van Leuken RJ, Luna-Vargas MP, Sixma TK,
Wolthuis RM and Medema RH: Usp39 is essential for mitotic spindle
checkpoint integrity and controls mRNA-levels of aurora B. Cell
Cycle. 7:2710–2719. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wan S, George SJ, Nicklin SA, Yim AP and
Baker AH: Overexpression of p53 increases lumen size and blocks
neointima formation in porcine interposition vein grafts. Mol Ther.
9:689–698. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mehta D, George SJ, Jeremy JY, Izzat MB,
Southgate KM, Bryan AJ, Newby AC and Angelini GD: External stenting
reduces long-term medial and neointimal thickening and platelet
derived growth factor expression in a pig model of arteriovenous
bypass grafting. Nat Med. 4:235–239. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Davies MG and Hagen PO: Pathobiology of
intimal hyperplasia. Br J Surg. 81:1254–1269. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Motwani JG and Topol EJ: Aortocoronary
saphenous vein graft disease: Pathogenesis, predisposition, and
prevention. Circulation. 97:916–931. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim SY, Jeoung NH, Oh CJ, Choi YK, Lee HJ,
Kim HJ, Kim JY, Hwang JH, Tadi S, Yim YH, et al: Activation of
NAD(P)H: Quinone oxidoreductase 1 prevents arterial restenosis by
suppressing vascular smooth muscle cell proliferation. Circ Res.
104:842–850. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vogt F, Zernecke A, Beckner M, Krott N,
Bosserhoff AK, Hoffmann R, Zandvoort MA, Jahnke T, Kelm M, Weber C
and Blindt R: Blockade of angio-associated migratory cell protein
inhibits smooth muscle cell migration and neointima formation in
accelerated atherosclerosis. J Am Coll Cardiol. 52:302–311. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mayr M, Li C, Zou Y, Huemer U, Hu Y and Xu
Q: Biomechanical stress-induced apoptosis in vein grafts involves
p38 mitogen-activated protein kinases. FASEB J. 14:261–270.
2000.PubMed/NCBI
|
|
28
|
Zou Y, Hu Y, Mayr M, Dietrich H, Wick G
and Xu Q: Reduced neointima hyperplasia of vein bypass grafts in
intercellular adhesion molecule-1-deficient mice. Circ Res.
86:434–440. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hu Y, Zou Y, Dietrich H, Wick G and Xu Q:
Inhibition of neointima hyperplasia of mouse vein grafts by locally
applied suramin. Circulation. 100:861–868. 1999. View Article : Google Scholar : PubMed/NCBI
|
